cbdMD, Inc. (NYSE:YCBD) received validation of its Novel Food application from the United Kingdom's Food Standards Agency for its natural plant-based CBD formulation. The company also anticipates validation of its application to the European Food Safety Authority in the coming weeks.
With this approval, cbdMD will now be allowed to sell its proprietary and validated tinctures, gummies, and capsules across the UK. The grant of validation was based on the company's extensive toxicological data, which contained all the requisite evidence to substantiate the safe consumption of the Company's products which contain cbdMD's proprietary blend of cannabinoids.
